<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Eczema</title>
    <link>https://refractor.io/tag/eczema/</link>
    <description>Eczema</description>
    <language>en-AU</language>
    <lastBuildDate>Wed, 25 Jun 2025 06:03:00 GMT</lastBuildDate>
    <atom:link href="https://refractor.io/tag/eczema/index.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>New eczema treatment provides relief in Phase 2 human trials</title>
      <link>https://refractor.io/disease/rezpegaldesleukin-atopic-dermatitis-immunotherapy-human-trials/</link>
      <description><![CDATA[<p><img src="https://assets.newatlas.com/dims4/default/d56ac01/2147483647/strip/true/crop/2000x1125+0+0/resize/1440x810!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg" srcset="https://assets.newatlas.com/dims4/default/6a1763f/2147483647/strip/true/crop/2000x1125+0+0/resize/440x248!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg 440w,https://assets.newatlas.com/dims4/default/825f5dc/2147483647/strip/true/crop/2000x1125+0+0/resize/725x408!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg 725w,https://assets.newatlas.com/dims4/default/3b3973f/2147483647/strip/true/crop/2000x1125+0+0/resize/800x450!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg 800w,https://assets.newatlas.com/dims4/default/ed33730/2147483647/strip/true/crop/2000x1125+0+0/resize/1200x675!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg 1200w,https://assets.newatlas.com/dims4/default/2512ab8/2147483647/strip/true/crop/2000x1125+0+0/resize/1920x1080!/format/webp/quality/85/?url=https%3A%2F%2Fnewatlas-brightspot.s3.amazonaws.com%2Fba%2F73%2F3ba2f5fc400f94ffbdff57ff6a2f%2Fdepositphotos-207376112-l.jpg 1920w" alt="A new immunotherapy injection has provided significant relief to eczema sufferers" /><p>A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the common side effects associated with other therapies.</p><p><a href="https://refractor.io/disease/rezpegaldesleukin-atopic-dermatitis-immunotherapy-human-trials/" data-cms-ai="0">Continue Reading</a></p><p><b>Category:</b> <a href="https://refractor.io/disease/" data-cms-ai="0">Illnesses and conditions</a>, <a href="https://refractor.io/medical/" data-cms-ai="0">Body and Mind</a></p><p><b>Tags:</b> <a href="https://newatlas.com/tag/eczema/" rel="tag" data-cms-ai="0">Eczema</a>, <a href="https://newatlas.com/tag/atopic-dermatitis/" rel="tag" data-cms-ai="0">Atopic dermatitis</a>, <a href="https://newatlas.com/tag/immunotherapy/" rel="tag" data-cms-ai="0">Immunotherapy</a>, <a href="https://newatlas.com/tag/inflammation/" rel="tag" data-cms-ai="0">Inflammation</a>, <a href="https://newatlas.com/tag/clinical-trials/" rel="tag" data-cms-ai="0">clinical trials</a></p>]]></description>
      <pubDate>Wed, 25 Jun 2025 06:03:00 GMT</pubDate>
      <guid>https://refractor.io/disease/rezpegaldesleukin-atopic-dermatitis-immunotherapy-human-trials/</guid>
      <dc:creator>Paul McClure</dc:creator>
    </item>
  </channel>
</rss>
